John Provias

2.4k citations
79 papers · 1.7k indexed · h-index 25
Topics
Glioma Diagnosis and Treatment (20 papers)Alzheimer's disease research and treatments (9 papers)Neurofibromatosis and Schwannoma Cases (8 papers)

In The Last Decade

John Provias

75 papers receiving 1.7k citations

Peers

John Provias
Comparison fields: 5 of 112
  • Molecular Biology 436
  • Neurology 373
  • Physiology 337
  • Genetics 277
  • Epidemiology 263
Replace Manabu Osoegawa with:
Manabu Osoegawa Japan
S. Michalak Poland
Francesca Nazio Italy
Hiroyuki Nakashima Japan
Manish Kumar India
John C. Fyfe United States
Cornelia Cudrici United States
Alexander Dressel Germany
Alpa Trivedi United States
Meihui Luo United States
John Provias relative to Manabu Osoegawa Japan Manabu Osoegawa's profile →
Citations per field
00.5×4.6×
Manabu Osoegawa · 1×
Citations per year

Countries citing papers authored by John Provias

Since Specialization
Citations

This map shows the geographic impact of John Provias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Provias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Provias more than expected).

Fields of papers citing papers by John Provias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Provias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Provias. The network helps show where John Provias may publish in the future.

Co-authorship network of co-authors of John Provias

This figure shows the co-authorship network connecting the top 25 collaborators of John Provias. A scholar is included among the top collaborators of John Provias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Provias. John Provias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 0
4 4
5 11
6 1
7 1
8 10
9 1
10 12
11 44
12 5
13 38
14 27
15 5
16 33
17 31
18 21
19 43
20 72

About John Provias

John Provias is a scholar working on Genetics, Neurology and Neurology, having authored 79 papers that have together received 1.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (20 papers), Alzheimer's disease research and treatments (9 papers) and Neurofibromatosis and Schwannoma Cases (8 papers). The work is most often cited by research in Genetics (277 citations), Neurology (373 citations) and Neurology (183 citations). John Provias has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Brian Jeynes, Abhijit Guha, Branavan Manoranjan, Matthias M. Feldkamp, Laurence E. Becker, Serge Puksa, Nelson C. Lau, Kevin P. Claffey, Mark Bernstein and David H. Gutmann. Their work appears in journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026